|
Navy proposes test of blood substitute product
Navy proposes test of blood substitute product
July 8, 2006
THE REGION
US drug regulators scheduled a private meeting to discuss a Navy proposal to test Biopure Inc.'s experimental blood substitute product in people being treated by emergency health workers. A panel of outside advisers to the Food and Drug Administration will meet Friday to review a proposal to test the substitute on as many as 1,000 trauma patients being rushed to medical facilities, according to Cambridge-based Biopure. The product, called Hemopure, has been linked in some patient studies to heart attacks. The FDA has turned down requests from Biopure to conduct patient studies. Under the Navy plan, the blood product may be administered without consent because test subjects may be unconscious or incapacitated. (Bloomberg)
|
You are currently accessing this Site as a guest. Please login or register by clicking Here
Linear Mode
